Book a demo

Company intelligence

Circio Holding ASA

The leader in circular RNA expression systems

Biotechnology Research
Oslo, NO
22 employees
Founded 2010
5 public signals

About Circio Holding ASA

Circio Holding ASA is a biotechnology company developing novel circular RNA expression technology for gene and cell therapy. Circio has established a unique circular RNA (circRNA) vector expression technology for next generation RNA, DNA and viral therapeutics. The proprietary circVec platform is based on a modular genetic construct designed for efficient biogenesis of multifunctional circRNA inside target cells. The circVec platform has applications in multiple therapeutic settings, including genetic medicine, cell therapy and chronic disease. It has demonstrated 75-fold increased RNA half-life and up to 50-fold enhanced protein expression vs conventional mRNA-based viral and non-viral vector systems, with the potential to become a new gold-standard gene expression technology. The circVec R&D activities are being conducted by the wholly owned subsidiary Circio AB in Stockholm, Sweden

Verified activity

Signals from Circio Holding ASA

5 published signals

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.

Circio Holding ASA Company Signals | SeedOps